Mot clé : VIH

Le VIH/sida au Canada

Combien de personnes sont-elles infectées par le VIH chaque jour au Canada? À quoi ressemble le taux d’infection au VIH dans des populations spécifiques?

Chaque année, les rapports de surveillance nous indiquent combien de Canadiens ont reçu un diagnostic de VIH. Par contre, étant donné qu’une grande partie des Canadiens séropositifs n’ont pas reçu de diagnostic, ces chiffres ne nous donnent pas un portrait exact.

Mots clés :

3 things to keep in mind about trans (men’s) inclusion in HIV prevention research

AydenScheimBy Ayden Scheim

In response to mounting evidence of the prevention benefits of pre-exposure prophylaxis (PrEP) use by HIV-negative gay and bisexual men, a discussion recently emerged on social media about the perceived exclusion of trans men1 who have sex with men from PrEP research studies.

In fact, trans men participate in many HIV prevention research studies, whether or not they are identified as trans when results are reported. Some do not identify as trans, but rather as men of trans experience or transitioned men, and are happy to check the “male” box without qualification. Other studies have explicitly included trans men and allowed them to self-identify. Regardless, some were upset that when results were reported, PrEP effectiveness among trans men was not addressed. In response, a number of well-intentioned non-trans men voiced their support for greater inclusion of trans men in biomedical and other HIV prevention research. While these statements are a testament to the progress gay and bisexual men’s communities are making in embracing men of trans experience, I feel compelled to offer a reality check about the inclusion of trans men in HIV prevention research.

There is a drug to prevent HIV. Why isn’t it approved in Canada?

By Bob Leahy2015 03 30 - Bob Leahy

Recent developments in prevention are pointing to worrying gaps in the community-based approach to HIV prevention in Canada.

Perhaps we have been used to having only a single prevention technology on our books for so long – think condoms – that our ducks are not always in a row when new ones like PrEP come along. Thus potholes in our response become apparent – and none leap in to fix them.

After a series of somewhat inconclusive PrEP trials, whose results were marred by adherence issues, the results of more stringent trials like the PROUD and IPERGAY studies are in, and they are good. So good, in fact, that it would now be foolish not to put PrEP right at the front of the shelf that features ways to stay HIV-negative.

Partager et conquérir : Mettre en commun nos compétences en matière de programmation

Par Erica Lee

20150105-ericaleeIl y a quelque temps, CATIE souhaitait savoir ce qui se faisait au pays pour évaluer les besoins des fournisseurs de services de première ligne en matière de VIH et d’hépatite C ainsi que les besoins des utilisateurs de services. En tant que spécialiste de l’information (ou bibliothécaire) ici chez CATIE, on m’a demandé de localiser tout rapport que je pourrais trouver sur le sujet.

Mots clés :

A clinician’s perspective on the criminalization of women living with HIV

2014 12 15 - Mona LoutfyBy Dr. Mona Loutfy

In Canada and in much of the Western world, thanks to the advent of combination antiretroviral therapy, there has been a clear improvement in health status and increased life expectancy of people living with HIV approaching that of the general population. However, despite these medical advances, negative public perception about HIV has yet to catch up to the reality that most clinicians encounter. The reality for the most part is of healthy and conscientious patients looking to improve their quality of life.